ImmunoGen Inc (NASDAQ:IMGN)
| 10.78 Data as of Jul 31 |  -0.33 / -2.97%Today’s Change | 10.31 Today|||52-Week Range 20.25 | -26.52% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Operating Activities | Net Income / Starting Line | -50.9M | -58.3M | -73.3M | -72.8M | |
| Depreciation | 4.8M | 4.9M | 4.6M | 4.6M | ||
| Total Other Cash Flow | 4.0M | 4.3M | 9.4M | 12.4M | ||
| Funds From Operations | -42.1M | -49.1M | -59.3M | -55.7M | ||
| Funds From/For Other Operating Expenses | -1.5M | -41.1M | -25.0M | 4.6M | ||
| Net Cash Flow - Operating Activities | -40.6M | -8.0M | -34.3M | -60.3M | ||
| Investing | Decrease In Investments | 834.0K | 1.2M | 0.00 | 0.00 | |
| Capital Expenditures | -1.5M | -2.0M | -2.9M | -3.8M | ||
| Other Investing - Uses | -182.0K | 0.00 | -60.0K | 0.00 | ||
| Other Investing - Sources | 0.00 | 168.0K | 0.00 | 74.0K | ||
| Net Cash Flow Investing | -882.0K | -660.0K | -3.0M | -3.7M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 81.0M | 90.7M | 7.0M | 98.0M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 81.0M | 90.7M | 7.0M | 98.0M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | 0.00 | 0.00 | -- |
| Net Change In Cash | 39.5M | 82.1M | -30.3M | 34.0M | ||
.
